Investigating use of diagnostic codes for post-COVID- 19 condition in Ontario health administrative data

调查安大略省卫生管理数据中 COVID-19 后遗症诊断代码的使用情况

阅读:1

Abstract

BACKGROUND: In January 2023 the Ontario Health Insurance Plan (OHIP) introduced a diagnostic code for post-COVID-19 condition (PCC). We used this code to estimate the incidence rate of PCC, to compare demographic and clinical characteristics of individuals who received a PCC code to those who didn't, and to investigate healthcare utilization of individuals who received a PCC code. METHODS: We conducted a retrospective cohort study using health administrative data from Ontario, Canada (population approximately 15 million). Individuals who had received a PCC diagnostic code between January 2023 and January 2024 were identified using OHIP, a physician billing database. For the entire population of Ontario, crude incidence rates of PCC were computed and patient characteristics (including age, sex, geographic location, comorbidities, and marginalization index) were collected and compared between individuals who had received a PCC code and those who hadn't using logistic regression models. Healthcare utilization rates for people who received a PCC code were compared pre-pandemic (January 1st, 2017 to March 31st, 2020), pre-PCC (April 1st, 2020 to 24-weeks pre-PCC diagnostic code), and post-PCC (24-weeks pre-PCC diagnostic code to study end). RESULTS: A PCC code was received by 7,343 individuals. Median age was 62, and 60% were female. When compared to the entire population of Ontario, female sex, older adults, Northern Ontario residents, and comorbid individuals had greater odds of receiving a PCC code. People who were visible minorities, immigrants, and had less access to material resources had lower odds of receiving a PCC code. Healthcare utilization rates, pre-pandemic, pre-PCC, and post-PCC were 14.59 (CI 13.63-15.61), 27.43 (CI 25.01-30.27), and 100.61 (CI 93.39-107.73) encounters per person-year respectively. CONCLUSION: The number of cases captured was lower than what Health Canada estimates would indicate and it is likely that the code is underrepresenting PCC in Ontario. The substantial increases in healthcare utilization suggests the code is capturing severe PCC cases. The characteristics of the cohort were similar to what has been described in peer-reviewed literature, suggesting that the patients in this cohort have PCC. This code could offer a promising way to study a large diverse population of people with PCC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。